Chris Frankenfield was named General Counsel of Xilio Therapeutics on April 9, 2021, according to biospace.com.
| Name | Chris Frankenfield |
|---|---|
| Role | General Counsel |
| Company | Xilio Therapeutics |
| Move | Appointment |
| Date | April 9, 2021 |
| Source | biospace.com |
Who is the general counsel of Xilio Therapeutics?
Chris Frankenfield took the General Counsel role at Xilio Therapeutics in April 2021, as reported by biospace.com. Legal leadership changes often, so check Xilio Therapeutics’s own leadership page for the latest. If you know of a newer move, tell us and we will update the directory.
More legal leadership moves at Xilio Therapeutics
- Ben Harshbarger Named Chief Legal Officer of Xilio Therapeutics (June 29, 2026)
- Caroline Hensley Named Chief Legal Officer of Xilio Therapeutics (December 16, 2024)
Other general counsel moves in April 2021
- Jim Jacobson Named General Counsel of Q-State Biosciences (April 30, 2021)
- Edward Sebold Named General Counsel of Kyndryl (April 30, 2021)
- Claudia Cantarella Named General Counsel of Broadway Technology (April 30, 2021)
- Barbara Levi Named Group General Counsel of UBS (April 30, 2021)
- Joanne Bal Named General Counsel of Vital Farms (April 29, 2021)
- Gina Beredo Named General Counsel of Owens Corning (April 29, 2021)
- D. Brock Denton Named General Counsel of Cintas (April 29, 2021)
- Alejandra Carvajal Named Chief Legal Officer of Mersana (April 29, 2021)
Planning your own next move?
Read our guide to becoming a general counsel and the in-house counsel salaries guide.
Browse every appointment in the General Counsel Directory.
Source: biospace.com. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.
Does this information need updating? Email us at info@inhouseblog.com.